Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Non-Current Deferred Tax Liability (2022 - 2023)

Spruce Biosciences (SPRB) has disclosed Non-Current Deferred Tax Liability for 2 consecutive years, with $249000.0 as the latest value for Q4 2023.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 36.8% to $249000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $249000.0, a 36.8% decrease, with the full-year FY2023 number at $249000.0, down 36.8% from a year prior.
  • Non-Current Deferred Tax Liability was $249000.0 for Q4 2023 at Spruce Biosciences, down from $394000.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $394000.0 in Q4 2022 to a low of $249000.0 in Q4 2023.